An experimental oral medication for hard-to-treat hypertension is one step closer to approval. According to Fierce Biotech, drugmaker AstraZeneca released new data from Phase III clinical trials that showed significant reductions in average nighttime blood pressure readings among trial participants compared to a placebo. Elevated nighttime blood pressure is associated with increased risk of heart attack, stroke, and other cardiovascular events.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
